Insider and Congress filings

Intuitive Surgical, Inc. (ISRG)

Medical Instruments & Supplies, listed on NASDAQ.

S&P 500Nasdaq 100339 insider transactions210 Congress tradeslast filed Nov 12, 2026

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

Scan to get
the app

EarningsQ3 FY2026 · reported Oct 20, 2026

Q3 FY2026: Beat +13.2% on adjusted EPS. Revenue beat by 4.9%. Next report Jan 28, 2027.

EPS Q3 FY2026

Reported$3.00
Consensus$2.65

Revenue Q3 FY2026

Reported$3.05B
Consensus$2.91B

Beat 6

Consensus $2.96 a share on $3.24B of revenue, the analysts’ forecast.

Every quarter

Money managers13F filings for Jun 30, 2026

7

of the 97 fund managers GetSignal tracks list Intuitive Surgical among their largest positions. Two Sigma held the most, $787.1M.

Tracked managers’ Q2 2026 moves

D1 Capitalopened+$228.3M
Trexquant Investmentadded+$75.2M

Each manager’s 13F against the one before, priced at the Jun 30, 2026 close: an estimate, from each manager’s 15 largest moves. Not investment advice.

Every manager

Insider tradesForm 4 · 20 open-market filings shown

20 open-market sales, all under 10b5‑1 plans.

Aug 20, 2026Nov 10, 2026

Sales under a plan

20 of 20 under a plan

A median 1 business day from trade to filing. Form 4 is due within two.

Every filing

CongressSTOCK Act disclosures to the House and Senate

20 Congress disclosures shown, from 2 members.

20dMedian delayof the 45 day limit
9 buys · 11 sellsPurchases and sales in the disclosures shown

6 members of Congress report a position in ISRG, by our estimate. Who holds it

Every Congress trade in ISRGEvery disclosure
Companyfrom the company's filings and listing, as of Nov 12, 2026

About Intuitive Surgical, Inc.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Chief executive
David J. Rosa
Employees
17,021
Listed since
Jun 16, 2000
Market value
$153.4B
Price to earnings (12 mo)
52.9
Net income per share, as reported (12 mo)
$8.47
Dividend yield
-

www.intuitive.com

GetSignal News1 article · newest first

GetSignal News

HeadlineSourceDate
Intuitive Surgical appoints Aaron Martin to its board, effective January 1, 2027The board grows from 10 to 11 members, and Martin's annual cash retainer is $70,000, prorated for the remaining fiscal year.Form 8-K and releaseNov 2, 2026

Written by GetSignal with AI from SEC filings and the company's own press releases; each article links to its source. Not investment advice.

Company news from every company we cover

Earnings6 reported quarters · next on Jan 28, 2027

Earnings

QuarterEPSEPS expectedRevenueRevenue expectedResult
Q3 FY2026reported Oct 20, 2026$3.00$2.65$3.0B$2.9BEPS beatRevenue beat
Q2 FY2026reported Jul 16, 2026$2.80$2.51$2.9B$2.8BEPS beatRevenue beat
Q1 FY2026reported Apr 21, 2026$2.80$2.51$2.8B$2.6BEPS beatRevenue beat
Q4 FY2025reported Jan 22, 2026$2.53$2.27$2.9B$2.8BEPS beatRevenue beat
Q3 FY2025reported Oct 21, 2025$2.40$1.99$2.5B$2.4BEPS beatRevenue beat
Q2 FY2025reported Jul 22, 2025$2.19$1.93$2.4B$2.4BEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Earnings call briefs1 call

Earnings call briefs

Q3 2026 call

Intuitive Surgical says price cuts will lower I&A revenue per procedure

Intuitive Surgical expects the reduction to be approximately 3% to 5% on a mix-constant basis once fully implemented.

Expected da Vinci instrument revenue per procedure reduction
Approximately 3% to 5% on a mix-constant basis once fully implemented
Expected start of pricing actions
First half of 2027, rolling out country by country
Expected China price reduction start
November

Read the full brief

Written by GetSignal with AI from each earnings call; every brief quotes the executives' own words. Key facts are what the company said on the call, not our forecast. Not investment advice.

Earnings call briefs from every company we cover

Analysts

Analyst ratings and price targets

Past year Each firm's latest target, newest first

Each firm's latest price target on ISRG, newest first
FirmRatingTargetActionDate
LeerinkOutperform$503Target set
RBC CapitalOutperform$550Target set
OppenheimerOutperform$500Target set
BairdOutperform$550Target set
Wells FargoOverweight$486Cut from $487
BarclaysOverweight$500Raised from $485
Raymond JamesOutperform$480Cut from $483
MizuhoNeutralrated Oct 21, 2026$415Raised from $400
BTIGBuy$454Cut from $469
HSBCHold$391Target set
UBSBuy$500Target set
StifelBuy$550Cut from $670
Truist SecuritiesBuy$510Cut from $580
BMO CapitalOutperform$518Initiated
Evercore ISIIn Line$430Target set
Goldman SachsNot stated$558Target set
BernsteinOutperform$750Raised from $740

Each firm's latest target from the past year, with the rating stated with its note. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice. A rating with its own date under it is the firm's latest from the past 120 days, where the note stated none.

7 other firms rated ISRG in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 12, 2026.

Proxy statementas filed for fiscal 2025 · proxy filed Mar 13, 2026

Executive pay

David J. Rosa’s pay as CEO came to $21.0M for fiscal 2025.
ExecutiveSalaryStock awardsOtherTotal
David J. RosaChief Executive Officer$859K$18.7M$1.5M$21.0M
Gary S. Guthart, Ph.D.Executive Chair of the Board of Directors$866K$16.0M$1.3M$18.1M
Jamie E. SamathExecutive Vice President, Chief Financial Officer and Enterprise Technology Leader$683K$6.9M$799K$8.4M
Henry L. CharltonExecutive Vice President and Chief Commercial and Marketing Officer$670K$4.8M$784K$6.2M
Gary H. LoebExecutive Vice President and Chief Legal and Compliance Officer$615K$4.3M$720K$5.6M
Mark P. BrosiusSenior Vice President and Chief Manufacturing and Supply Chain Officer$534K$4.5M$484K$5.5M

The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing

13F filings13F positions as of Jun 30, 2026

Institutional holders

2,263 institutions reported Intuitive Surgical shares in 13F filings for Jun 30, 2026.
HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$11.9B30,024,648-0.2%8.47%
Vanguard Capital Management LLC$9.2B23,131,099+0.2%6.53%
State Street Corp$6.4B16,063,040+1.4%4.53%
Invesco Ltd.$4.7B11,843,563+58.9%3.34%
T. Rowe Price Associates, Inc.$4.5B11,256,570-10.1%3.18%
Geode Capital Management, LLC$3.4B8,534,767+0.8%2.41%
Capital World Investors$3.1B7,742,681-3.8%2.18%
Vanguard Portfolio Management LLC$2.9B7,243,264+0.1%2.04%
Morgan Stanley$2.6B6,561,322+8.3%1.85%
Norges Bank$2.0B4,954,874New1.40%
JPMorgan Chase & Co.$1.7B4,231,033-7.9%1.19%
FMR LLC$1.7B4,251,130-22.4%1.20%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. New: not in this holder's prior 13F as reported; a change of filer ID can also show as new. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

13F filings7 managers

Tracked fund managers holding ISRG

ManagerValueSharesShare of book
Two Sigma$787.1M1,979,1280.6%
Alyeska Investment Group$423.9M1,065,8691.1%
Coatue ManagementPhilippe Laffont$315.6M793,7040.6%
Holocene Advisors$310.8M781,4650.7%
D1 Capital PartnersDaniel Sundheim$228.3M574,2000.7%
Trexquant Investment$100.5M252,7230.6%
OrbiMed$62.8M157,9001.2%

7 of the 97 fund managers we track list ISRG shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.

Form 420 filings shown · newest filing first

Open-market insider trades

InsiderActionSharesPriceValueTrade dateDelay
(business days)
Gary LoebEVP & Chief Legal and ComplianSold · scheduled400$458.15$183KNov 10, 2026filed Nov 12, 20261d
Gary S. GuthartDirectorSold · scheduled10,000$457.34$4.6MNov 4, 2026filed Nov 5, 20261d
Craig H. BarrattDirectorSold · scheduled1,150$460.00$529KNov 4, 2026filed Nov 5, 20261d
Mark BrosiusEVP & Chief Mfg and Supply ChaSold · scheduled63$453.60$29KOct 30, 2026filed Nov 2, 20261d
Mark BrosiusEVP & Chief Mfg and Supply ChaSold · scheduled61$447.85$27KOct 29, 2026filed Nov 2, 20262d
Fredrik WidmanVP Corporate ControllerSold · scheduled5,448$436.06$2.4MOct 30, 2026filed Nov 2, 20261d
Mark BrosiusEVP & Chief Mfg and Supply ChaSold · scheduled61$441.60$27KOct 28, 2026filed Oct 28, 20260d
Mark BrosiusEVP & Chief Mfg and Supply ChaSold · scheduled61$451.63$28KOct 27, 2026filed Oct 28, 20261d
Mark BrosiusEVP & Chief Mfg and Supply ChaSold · scheduled61$451.75$28KOct 26, 2026filed Oct 28, 20262d
Craig H. BarrattDirectorSold · scheduled1,150$443.80$510KOct 23, 2026filed Oct 26, 20261d
Fredrik WidmanVP Corporate ControllerSold · scheduled4,047$453.21$1.8MOct 23, 2026filed Oct 26, 20261d
Patricia L. WadorsSVP Chief Human Resources OffiSold · scheduled1,078$443.80$478KOct 23, 2026filed Oct 26, 20261d
Gary S. GuthartDirectorSold · scheduled20,095$451.61$9.1MOct 23, 2026filed Oct 26, 20261d
Fredrik WidmanVP Corporate ControllerSold · scheduled543$374.44$203KSep 15, 2026filed Sep 16, 20261d
Mark BrosiusEVP & Chief Mfg and Supply ChaSold · scheduled25$365.79$9KSep 11, 2026filed Sep 11, 20260d
Mark BrosiusEVP & Chief Mfg and Supply ChaSold · scheduled23$347.66$8KSep 10, 2026filed Sep 11, 20261d
Mark BrosiusEVP & Chief Mfg and Supply ChaSold · scheduled23$350.20$8KSep 9, 2026filed Sep 9, 20260d
Mark BrosiusEVP & Chief Mfg and Supply ChaSold · scheduled46$361.23$17KSep 8, 2026filed Sep 9, 20261d
Mark BrosiusEVP & Chief Mfg and Supply ChaSold · scheduled77$375.57$29KAug 21, 2026filed Aug 21, 20260d
Mark BrosiusEVP & Chief Mfg and Supply ChaSold · scheduled77$396.37$31KAug 20, 2026filed Aug 21, 20261d

One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.

Other Form 4 activity (20)
InsiderEventSharesDate
Craig H. BarrattDirectorOption exercise1,150Nov 4, 2026
Fredrik WidmanVP Corporate ControllerOption exercise3,531Oct 30, 2026
Craig H. BarrattDirectorOption exercise1,150Oct 23, 2026
Fredrik WidmanVP Corporate ControllerOption exercise2,442Oct 23, 2026
Patricia L. WadorsSVP Chief Human Resources OffiTax withholding1,062Oct 10, 2026
Patricia L. WadorsSVP Chief Human Resources OffiOption exercise2,140Oct 10, 2026
Gary LoebEVP & Chief Legal and ComplianTax withholding1,296Oct 10, 2026
Gary LoebEVP & Chief Legal and ComplianOption exercise2,612Oct 10, 2026
Fredrik WidmanVP Corporate ControllerOption exercise1,089Sep 15, 2026
David J. RosaChief Executive Officer (CEO)Tax withholding947Jul 10, 2026
David J. RosaChief Executive Officer (CEO)Option exercise1,910Jul 10, 2026
David J. RosaChief Executive Officer (CEO)Tax withholding674Jun 10, 2026
David J. RosaChief Executive Officer (CEO)Option exercise1,358Jun 10, 2026
Iman JeddiSVP & GM Da Vinci Platforms &Option exercise5,625Jun 1, 2026
Gary S. GuthartDirectorStock award554Apr 30, 2026
Craig H. BarrattDirectorStock award643Apr 30, 2026
Craig H. BarrattDirectorOption exercise750Apr 30, 2026
Joseph C. BeeryDirectorStock award554Apr 30, 2026
Joseph C. BeeryDirectorOption exercise531Apr 30, 2026
Lewis ChewDirectorStock award554Apr 30, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

STOCK Act20 disclosures of 210 on record · median 20d of the 45 allowed

Congress trades in ISRG

Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.

MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Ro KhannaStockPurchase$1,001 - $15,000+10.9% since the tradeEstimated entry price $405.18, close on Fri Sep 25Current price $449.53, close on Wed Nov 11Sep 25, 2026Oct 7, 202612d
Ro KhannaStockSale$1,001 - $15,000+19.7% since the saleEstimated exit price $375.41, close on Mon Aug 3Current price $449.53, close on Wed Nov 11Aug 3, 2026Sep 4, 202632d
Ro KhannaStockSale$1,001 - $15,000+14.3% since the saleEstimated exit price $393.38, close on Mon Aug 10Current price $449.53, close on Wed Nov 11Aug 10, 2026Sep 4, 202625d
Ro KhannaStockPurchase$1,001 - $15,000+20.3% since the tradeEstimated entry price $373.57, close on Mon Aug 24Current price $449.53, close on Wed Nov 11Aug 24, 2026Sep 4, 202611d
Ro KhannaStockSale$1,001 - $15,000+27.3% since the saleEstimated exit price $353.17, close on Mon Jul 20Current price $449.53, close on Wed Nov 11Jul 20, 2026Aug 7, 202618d
Alan ArmstrongSelfStockPurchase$1,001 - $15,000-0.7% since the tradeEstimated entry price $452.66, close on Fri Mar 27Current price $449.53, close on Wed Nov 11Mar 27, 2026Jul 21, 2026116d
Ro KhannaStockPurchase$1,001 - $15,000+11.7% since the tradeEstimated entry price $402.30, close on Tue Jun 2Current price $449.53, close on Wed Nov 11Jun 2, 2026Jul 6, 202634d
Ro KhannaStockSale$1,001 - $15,000+7.8% since the saleEstimated exit price $417.07, close on Tue Jun 16Current price $449.53, close on Wed Nov 11Jun 16, 2026Jul 6, 202620d
Ro KhannaStockSale$1,001 - $15,000+11.5% since the saleEstimated exit price $403.18, close on Tue Jun 23Current price $449.53, close on Wed Nov 11Jun 23, 2026Jul 6, 202613d
Ro KhannaStockPurchase$15,001 - $50,000+13.0% since the tradeEstimated entry price $397.68, close on Tue Jun 30Current price $449.53, close on Wed Nov 11Jun 30, 2026Jul 6, 20266d
Ro KhannaStockSale$1,001 - $15,000-1.8% since the saleEstimated exit price $457.78, close on Fri May 1Current price $449.53, close on Wed Nov 11May 1, 2026Jun 9, 202639d
Ro KhannaStockPurchase$1,001 - $15,000-1.8% since the tradeEstimated entry price $457.78, close on Fri May 1Current price $449.53, close on Wed Nov 11May 1, 2026Jun 9, 202639d
Ro KhannaStockPurchase$15,001 - $50,000+6.7% since the tradeEstimated entry price $421.12, close on Fri May 15Current price $449.53, close on Wed Nov 11May 15, 2026Jun 9, 202625d
Ro KhannaStockSale$15,001 - $50,000+7.4% since the saleEstimated exit price $418.55, close on Wed May 27Current price $449.53, close on Wed Nov 11May 27, 2026Jun 9, 202613d
Ro KhannaStockSale$15,001 - $50,000-2.1% since the saleEstimated exit price $458.96, close on Mon Apr 13Current price $449.53, close on Wed Nov 11Apr 13, 2026May 11, 202628d
Ro KhannaStockSale$1,001 - $15,000-6.8% since the saleEstimated exit price $482.22, close on Fri Apr 24Current price $449.53, close on Wed Nov 11Apr 24, 2026May 11, 202617d
Ro KhannaStockPurchase$15,001 - $50,000-6.0% since the tradeEstimated entry price $478.04, close on Mon Mar 23Current price $449.53, close on Wed Nov 11Mar 23, 2026Apr 7, 202615d
Ro KhannaStockPurchase$15,001 - $50,000-5.6% since the tradeEstimated entry price $476.32, close on Thu Feb 5Current price $449.53, close on Wed Nov 11Feb 5, 2026Mar 9, 202632d
Ro KhannaStockSale$1,001 - $15,000-8.9% since the saleEstimated exit price $493.35, close on Tue Feb 17Current price $449.53, close on Wed Nov 11Feb 17, 2026Mar 9, 202620d
Ro KhannaStockSale$1,001 - $15,000-10.2% since the saleEstimated exit price $500.76, close on Wed Feb 18Current price $449.53, close on Wed Nov 11Feb 18, 2026Mar 9, 202619d

Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in ISRG filterable by party, chamber, type and account.

STOCK Act6 members · estimate, as of Nov 12, 2026

Members of Congress reporting a position

6 members report a position (estimated).
MemberParty, chamberEstimated positionShare of their portfolio
Gilbert Ray Cisneros, Jr.Democrat · House$15,001 - $50,0000.1%
Josh GottheimerDemocrat · House$1,001 - $15,000<0.1%
Lucy McBathDemocrat · House$1,001 - $15,0000.1%
Michael A. RulliRepublican · House$1,001 - $15,0000.6%
Robert BresnahanRepublican · House$1,001 - $15,0000.1%
William R. KeatingDemocrat · House$1,001 - $15,0000.7%

The largest estimated position is in the $15,001 - $50,000 band. Estimate, as of Nov 12, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

On Form 4, code P is an open-market purchase and S an open-market sale; a sale marked scheduled was set up in advance under a Rule 10b5-1 plan. Awards, option exercises, tax withholding and gifts (A, M, F and G) are listed under Other Form 4 activity and never counted as either.

A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.

Data as of Nov 12, 2026.

Methodology · Guide to Form 4 · Guide to the STOCK Act

Questions

What the filings on ISRG show and how current they are.

Are insiders buying or selling ISRG?

Across the 20 most recent open-market filings shown here, 0 were purchases and 20 were sales. 20 were scheduled in advance under a Rule 10b5-1 plan.

Which members of Congress have traded ISRG?

Ro Khanna and Alan Armstrong disclosed ISRG transactions in the filings shown here.

Which members of Congress hold ISRG?

6 members of Congress report a position in ISRG in the estimate we hold as of Nov 12, 2026. The largest estimated position belongs to Gilbert Ray Cisneros, Jr.; the next largest, in the $1,001 - $15,000 band, include Josh Gottheimer and Lucy McBath. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is ISRG in the S&P 500 or the Nasdaq 100?

Intuitive Surgical, Inc. is a current member of the S&P 500 and Nasdaq 100, per the membership list we hold as of Nov 12, 2026. Current members of either index get a page here whatever their filing history.

How quickly are ISRG trades disclosed?

Insider filings on this page reached the public a median of 1 business day after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 20 days, against the 45 the STOCK Act allows.

Related companies

traded by the same members

See every company we track